HYDROCHLOROTHIAZIDE capsule United States - English - NLM (National Library of Medicine)

hydrochlorothiazide capsule

cardinal health - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - hydrochlorothiazide 12.5 mg - hydrochlorothiazide capsules are indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. unlike potassium sparing combination diuretic products, hydrochlorothiazide capsules may be used in those patients in whom the development of hyperkalemia cannot be risked, including patients taking ace inhibitors. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. diuretics are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy. dependent edema in pregnancy resulting from restriction of venous return by the expanded uterus is properly tre

CANDESARTAN HCTZ AN 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

candesartan hctz an 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet bottle

amneal pharma australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: magnesium stearate; carmellose calcium; maize starch; lactose monohydrate; macrogol 8000; hyprolose; iron oxide red - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

CANDESARTAN HCTZ AN 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

candesartan hctz an 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet bottle

amneal pharma australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: magnesium stearate; maize starch; macrogol 8000; lactose monohydrate; carmellose calcium; hyprolose; iron oxide yellow - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Ramipril/Hydrochlorothiazide TAD 2.5 mg/12.5 mg tablets Malta - English - Medicines Authority

ramipril/hydrochlorothiazide tad 2.5 mg/12.5 mg tablets

tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril, hydrochlorothiazide - tablet - ramipril 2.5 mg hydrochlorothiazide 12.5 mg - agents acting on the renin-angiotensin system

SEVIKAR HCT 40/5/12.5 olmesartan medoxomil 40 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sevikar hct 40/5/12.5 olmesartan medoxomil 40 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5 mg tablet blister pack

organon pharma pty ltd - amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg); olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: magnesium stearate; croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

SEVIKAR HCT 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sevikar hct 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack

organon pharma pty ltd - olmesartan medoxomil, quantity: 20 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg); hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

Amlodipin/Valsartan/HCT Sandoz 5 mg - 160 mg - 12,5 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amlodipin/valsartan/hct sandoz 5 mg - 160 mg - 12,5 mg film-coat. tabl.

sandoz sa-nv - amlodipine besilate 6,94 mg - eq. amlodipine 5 mg; valsartan 160 mg; hydrochlorothiazide 12,5 mg - film-coated tablet - 5 mg - 160 mg - 12,5 mg - amlodipine besilate 6.94 mg; valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan, amlodipine and hydrochlorothiazide

Co-Bisoprolanmyl 5 mg - 12.5 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

co-bisoprolanmyl 5 mg - 12.5 mg film-coat. tabl.

viatris gx bv-srl - hydrochlorothiazide 12,5 mg; bisoprolol fumarate 5 mg - film-coated tablet - 5 mg - 12,5 mg - hydrochlorothiazide 12.5 mg; bisoprolol fumarate 5 mg - bisoprolol and thiazides

Co-Bisoprolol EG 5 mg - 12.5 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

co-bisoprolol eg 5 mg - 12.5 mg film-coat. tabl.

eg sa-nv - hydrochlorothiazide 12,5 mg; bisoprolol fumarate 5 mg - eq. bisoprolol 4,24 mg - film-coated tablet - 5 mg - 12,5 mg - hydrochlorothiazide 12.5 mg; bisoprolol fumarate 5 mg - bisoprolol and thiazides

Co-Bisoprolol Teva 5 mg - 12,5 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

co-bisoprolol teva 5 mg - 12,5 mg film-coat. tabl.

teva pharma belgium sa-nv - hydrochlorothiazide 12,5 mg; bisoprolol fumarate 5 mg - film-coated tablet - 5 mg - 12,5 mg - hydrochlorothiazide 12.5 mg; bisoprolol fumarate 5 mg - bisoprolol and thiazides